RES-loaded pegylated CS NPs: For efficient ocular delivery

IET Nanobiotechnology

Volumn 11, Issue 1, 2017, Pages 32-39

  Pandian, Saravanakumar ^a   Jeevanesan, Vinoth ^a   Ponnusamy, Chandrasekar ^a   Natesan, Subramanian ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GELATION; OPHTHALMOLOGY; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

CHORIO-ALLANTOIC MEMBRANES; CONTROLLED RELEASE; ENTRAPMENT EFFICIENCY; FLUORESCEIN ISOTHIOCYANATE; INTRA OCULAR PRESSURE; IONIC GELATION METHOD; NANOPARTICLE (NPS); POLYDISPERSITY INDICES;

MERCURY COMPOUNDS;

ANGIOGENESIS INHIBITOR; BIOCOMPATIBLE COATED MATERIAL; CHITOSAN; DELAYED RELEASE FORMULATION; MACROGOL DERIVATIVE; NANOCAPSULE; RESVERATROL; STILBENE DERIVATIVE;

ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; CORNEA; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG ABSORPTION; IN VITRO STUDY; INTRAOCULAR DRUG ADMINISTRATION; LEPORIDAE; PARTICLE SIZE; ULTRASTRUCTURE;

ADMINISTRATION, OPHTHALMIC; ANGIOGENESIS INHIBITORS; ANIMALS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; CORNEA; DELAYED-ACTION PREPARATIONS; DIFFUSION; IN VITRO TECHNIQUES; NANOCAPSULES; OCULAR ABSORPTION; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RABBITS; STILBENES;

EID: 85017548245     PISSN: 17518741     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-nbt.2016.0069     Document Type: Conference Paper

References (77)

1. Medeiros, F.A., Weinreb, R.N.: 'Medical backgrounders: glaucoma', Drugs Today (Barc), 2002, 38, (8), pp. 563-570
2. Susanna, R.Jr., De Moraes, C.G., Cioffi, G.A., et al.: 'Why do people (still) go blind from glaucoma?', Transl. Vis. Sci. Technol., 2015, 4, (2), p. 1
3. Doganay, S., Borazan, M., Iraz, M., et al.: 'The effect of resveratrol in experimental cataract model formed by sodium selenite', Curr. Eye Res., 2006, 31, (2), pp. 147-153
4. Thiagarajan, R., Manikandan, R.: 'Antioxidants and cataract', Free Radic. Res., 2013, 47, (5), pp. 337-345
5. Yadav, U.C., Kalariya, N.M., Ramana, K.V.: 'Emerging role of antioxidants in the protection of uveitis complications', Curr. Med. Chem., 2011, 18, (6), pp. 931-942
6. Selvi, R., Angayarkanni, N., Biswas, J., et al.: 'Total antioxidant capacity in Eales' disease, uveitis & cataract', Indian J. Med. Res., 2011, 134, (1), pp. 83-90
7. Johnson, L., Schaffer, D., Boggs, T.R.Jr.: 'The premature infant, vitamin E deficiency and retrolental fibroplasia', Am. J. Clin. Nutr., 1974, 27, (10), pp. 1158-1173
8. Erdurmus, M., Yagci, R.O., Karadag, R., et al.: 'Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma', Curr. Eye Res., 2011, 36, (8), pp. 713-718
9. Kang, J.H., Pasquale, L.R., Willett, W., et al.: 'Antioxidant intake and primary open-angle glaucoma: A prospective study', Am. J. Epidemiol., 2003, 158, (4), pp. 337-346
10. Johnson, E.J.: 'Age-related macular degeneration and antioxidant vitamins: recent findings', Curr. Opin. Clin. Nutr. Metab. Care, 2010, 13, (1), pp. 28-33
11. Fletcher, A.E., Bentham, G.C., Agnew, M., et al.: 'Sunlight exposure, antioxidants and age-related macular degeneration', Arch. Ophthalmol., 2008, 126, (10), pp. 1396-1403
12. Tanito, M., Kaidzu, S., Takai, Y., et al.: 'Correlation between systemic oxidative stress and intraocular pressure level', PLoS One, 2015, 10, (7), p. e0133582
13. Rahman, K.: 'Studies on free radicals, antioxidants and co-factors', Clin. Interv. Aging., 2007, 2, (2), pp. 219-236
14. Tanito, M., Kaidzu, S., Takai, Y., et al.: 'Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome', PLoS One, 2012, 7, (11), p. e49680
15. Hammond, B.R., Johnson, B.A., George, E.R.: 'Oxidative photodegradation of ocular tissues: beneficial effects of filtering and exogenous antioxidants', Exp. Eye Res., 2014, 129, pp. 135-150
16. Munemasa, Y., Kitaoka, Y.: 'Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection', Front. Cell. Neurosci., 2012, 6, p. 60
17. Goel, M., Picciani, R.G., Lee, R.K., et al.: 'Aqueous humor dynamics: A review', Open Ophthalmol. J., 2010, 4, pp. 52-59
18. Ammar, D.A., Hamweyah, K.M., Kahook, M.Y.: 'Antioxidants protect trabecular meshwork cells from hydrogen peroxide-induced cell death', Transl. Vis. Sci. Technol., 2012, 1, (1), p. 4
19. Yorio, T., Krishnamoorthy, R., Prasanna, G.: 'Endothelin: is it a contributor to glaucoma pathophysiology?', J. Glaucoma, 2002, 11, (3), pp. 259-270
20. Kahler, J., Ewert, A., Weckmuller, J., et al.: 'Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells', J. Cardiovasc. Pharmacol., 2001, 38, (1), pp. 49-57
21. Hooper, A., Cassidy, A.: 'A review of the health care potential of bioactive compounds', J. Sci. Food Agric., 2006, 86, (12), pp. 1805-1813
22. Pandey, K.B., Rizvi, S.I.: 'Plant polyphenols as dietary antioxidants in human health and disease', Oxidative Med. Cell. Longevity, 2009, 2, (5), pp. 270-278
23. Anisimova, N.Y., Kiselevsky, M.V., Sosnov, A.V., et al.: 'Trans-, cis-and dihydro-resveratrol: A comparative study', Chem. Cent. J., 2011, 20 (5), p. 88
24. Bola, C., Bartlett, H., Eperjesi, F.: 'Resveratrol and the eye: activity and molecular mechanisms', Graefes. Arch. Clin. Exp. Ophthalmol., 2014, 252, (5), pp. 699-713
25. Song, B.J., Caprioli, J.: 'New directions in the treatment of normal tension glaucoma', Indian J. Ophthalmol., 2014, 62, (5), pp. 529-537
26. Katas, H., Alpar, H.O.: 'Development and characterisation of chitosan nanoparticles for siRNA delivery', J. Control Release, 2006, 115, (2), pp. 216-225
27. Luna, C., Li, G., Liton, P.B., et al.: 'Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells', Food Chem. Toxicol., 2009, 47, (1), pp. 198-204
28. Pirhan, D., Yuksel, N., Emre, E., et al.: 'Riluzole and resveratrol-induced delay of retinal ganglion cell death in an experimental model of glaucoma', Curr. Eye Res., 2016, 41, (1), pp. 59-69
29. Razali, N., Agarwal, R., Agarwal, P., et al.: 'Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension', Clin. Exp. Ophthalmol., 2015, 43, pp. 54-66
30. Casettari, L., Vllasaliu, D., Castagnino, E., et al.: 'PEGylated chitosan derivatives: synthesis, characterizations and pharmaceutical applications', Prog. Polym. Sci., 2012, 37, (5), pp. 659-685
31. Zhang, M., Li, X.H., Gong, Y.D., et al.: 'Properties and biocompatibility of chitosan films modified by blending with PEG', Biomaterials, 2002, 23, (13), pp. 2641-2648
32. De Campos, A., Sanchez, A., Alonso, M.J.: 'Chitosan nanoparticles: A new vehicle for the improvement of the ocular retention of drugs. Application to cyclosporin A', Int. J. Pharm., 2001, 224, pp. 159-168
33. Bhattarai, N., Ramay, H.R., Gunn, J., et al.: 'PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release', J. Control Release, 2005, 103, (3), pp. 609-624
34. Quellec, P., Gref, R., Dellacherie, E., et al.: 'Protein encapsulation within poly(ethylene glycol)-coated nanosphere. II. Controlled release properties', J. Biomed. Mater. Res., 1999, 47, pp. 388-395
35. Chuah, L.H., Billa, N., Roberts, C.J., et al.: 'Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon', Pharm. Dev. Technol., 2013, 18, (3), pp. 591-599
36. Biasutto, L., Marotta, E., Garbisa, S., et al.: 'Determination of quercetin and resveratrol in whole blood-implications for bioavailability studies', Molecules, 2010, 15, (9), pp. 6570-6579
37. Sanna, V., Siddiqui, I.A., Sechi, M., et al.: 'Resveratrol-loaded nanoparticles based on poly (epsilon-caprolactone) and poly (D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment', Mol. Pharm., 2013, 10, (10), pp. 3871-3881
38. Hippalgaonkar, K., Adelli, G.R., Hippalgaonkar, K., et al.: 'Indomethacinloaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation', J. Ocul. Pharmacol. Ther., 2013, 29, (2), pp. 216-228
39. Luepke, N.P.: 'Hen's egg chorioallantoic membrane test for irritation potential', Food Chem. Toxicol., 1985, 23, (2), pp. 287-291
40. Steiling, W., Bracher, M., Courtellemont, P., et al.: 'The HET-CAM, a useful in vitro assay for assessing the eye irritation properties of cosmetic formulations and ingredients', Toxicol. In Vitro, 1999, 13, (2), pp. 375-384
41. Krenn, L., Paper, D.H.: 'Inhibition of angiogenesis and inflammation by an extract of red clover (Trifoliumpratense L.)', Phytomedicine, 2009, 16, (12), pp. 1083-1088
42. Abdelkader, H., Ismail, S., Kamal, A., et al.: 'Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery', J. Pharm. Sci., 2011, 100, (5), pp. 1833-1846
43. Rathore, M.S., Majumdar, D.K.: 'Effect of formulation factors on in-vitro transcorneal permeation of gatifloxacin from aqueous drops', AAPS Pharm. Sci. Tech., 2006, 7, (3), p. 57
44. Zhou, W., Wang, Y., Jian, J., et al.: 'Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B', Int. J. Nanomed., 2013, 8, pp. 3715-3728
45. Kaur, I.P., Garg, A., Singla, A.K., et al.: 'Vesicular systems in ocular drug delivery: an overview', Int. J. Pharm., 2004, 269, (1), pp. 1-14
46. Ammar, H.O., Salama, H.A., Ghorab, M., et al.: 'Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride', AAPS Pharm. Sci. Tech., 2009, 10, (3), pp. 808-819
47. Winum, J.Y., Casini, A., Mincione, F., et al.: 'Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits', Bioorg. Med. Chem. Lett., 2004, 14, (1), pp. 225-229
48. Hu, Y.Q., Jiang, H.L., Xu, C.N., et al.: 'Preparation and characterization of poly (ethylene glycol)-g-chitosan with water-and organosolubility', Carbohydr. Polym., 2005, 61, (4), pp. 472-479
49. Bodmeier, R., Chen, H., Paeratakul, O.: 'A novel approach to the delivery of microparticles or nanoparticles', Pharm. Res., 1989, 6, pp. 413-417
50. Janes, K.A., Calvo, P., Alonso, M.J.: 'Polysaccharide colloidal particles as delivery systems for macromolecules', Adv. Drug Deliv. Rev., 2001, 47, (1), pp. 83-97
51. Veronese, F.M., Pasut, G.: 'Pegylation, successful approach for drug delivery', Drug Discov. Today, 2005, 10, pp. 1451-1458
52. Malhotra, M., Lane, C., Tomaro-Duchesneau, C., et al.: 'A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis', Int. J. Nanomed., 2011, 6, pp. 485-494
53. Wu, Y., Yang, W., Wang, C., et al.: 'Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate', Int. J. Pharm., 2005, 295, (12), pp. 235-245
54. Quellec, P., Gref, R., Perrin, L., et al.: 'Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization', J. Biomed. Mater. Res., 1998, 42, (1), pp. 45-54
55. Mendes, J.B., Riekes, M.K., de Oliveira, V.M., et al.: 'PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes', Sci. World J., 2012, 2012, p. 542937
56. Amrite, A.C., Edelhauser, H.F., Singh, S.R., et al.: 'Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration', Mol. Vis., 2008, 14, pp. 150-160
57. Nagarwal, R.C., Kant, S., Singh, P.N., et al.: 'Polymeric nanoparticulate system: A potential approach for ocular drug delivery', J. Control Release, 2009, 136, pp. 2-13
58. Parveen, S., Sahoo, S.K.: 'Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery', Eur. J. Pharmacol., 2011, 30, (23), pp. 372-383
59. Bayens, V., Gurny, R.: 'Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations', Pharm. Acta Helvetiae, 1997, 72, pp. 191-202
60. Abelson, M.B., Udell, I.J., Weston, J.H.: 'Normal human tear pH by direct measurement', Arch. Ophthalmol., 1981, 99, (2), p. 301
61. Vasconcelos, A., Vega, E., Perez, Y., et al.: 'Conjugation of cell-penetrating peptides with poly (lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery', Int. J. Nanomed., 2015, 10, pp. 609-631
62. Ludwig, A.: 'The use of mucoadhesive polymers in ocular drug delivery', Adv. Drug Deliv. Rev., 2005, 57, (11), pp. 1595-1639
63. Shi, S., Zhang, Z., Luo, Z., et al.: 'Chitosan grafted methoxy poly (ethylene glycol)-poly (ϵ-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac', Sci. Rep., 2015, 5, p. 11337
64. Lehr, C.M., Bouwstra, J.A., Schacht, E.H., et al.: 'In vitro evaluation of mucoadhesive properties of chitosan and other natural polymers', Int. J. Pharm., 1992, 78, pp. 43-48
65. De Campos, A.M., Sanchez, A., Gref, R., et al.: 'The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa', Eur. J. Pharm. Sci., 2003, 20, (1), pp. 73-81
66. Kim, H., Robinson, S.B., Csaky, K.G.: 'Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina', Pharm. Res., 2009, 26, pp. 329-337
67. Koo, H., Moon, H., Han, H., et al.: 'The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection', Biomaterials, 2012, 33, pp. 3485-3493
68. Peeters, L., Sanders, N.N., Braeckmans, K., et al.: 'Vitreous: A barrier to nonviral ocular gene therapy', Invest. Ophthalmol. Vis. Sci., 2005, 46, pp. 3553-3561
69. Sanders, N.N., Peeters, L., Lentacker, I., et al.: 'Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer', J. Control Release, 2007, 122, pp. 226-235
70. Hamalainen, K.M., Kananen, K., Auriola, S., et al.: 'Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera', Invest. Ophthalmol. Vis. Sci., 1997, 38, (3), pp. 627-634
71. Xu, Q., Boylan, N.J., Suk, J.S., et al.: 'Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo', J. Control Release, 2013, 167, (1), pp. 76-84
72. Otsuka, H., Nagasaki, Y., Kataoka, K.: 'PEGylated nanoparticles for biological and pharmaceutical applications', Adv. Drug Deliv. Rev., 2003, 55, pp. 403-419
73. Thorpe, R.M., Kolker, A.E.: 'A tonographic study of water loading in rabbits', Arch. Ophthalmol., 1967, 77, pp. 238-243
74. Bonomi, L., Tomazzoli, L., Jaria, D.: 'An improved model of experimentally induced ocular hypertension in the rabbit', Invest. Ophthalmol., 1976, 15, pp. 781-784
75. Sears, D., Sears, M.: 'Blood-aqueous barrier and alpha-chymotrypsin glaucoma in rabbits', Am. J. Ophthalmol., 1974, 77, (3), pp. 378-383
76. Orihashi, M., Shima, Y., Tsuneki, H., et al.: 'Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits', Biol. Pharm. Bull., 2005, 28, (1), pp. 65-68
77. Muslim, T., Morimoto, M., Saimoto, H., et al.: 'Synthesis and bioactivities of poly (ethylene glycol)-chitosan hybrids', Carbohydr. Polym., 2001, 46, pp. 323-330